Addressing the Worldwide Impact of Endometriosis for Global Health Engagement Month

This December, Global Health Engagement Month, it is crucial to spotlight endometriosis—a disease that transcends geographical borders, affecting approximately 190 million individuals worldwide [1]. This chronic inflammatory condition not only impacts personal health but also has far-reaching social, economic, and healthcare implications across the globe.

The Global Burden of Endometriosis

Endometriosis is one of the most common gynecological conditions worldwide, yet it remains underrecognized and underfunded in many regions. Its effects extend well beyond the reproductive system, influencing mental health, employment, relationships, and overall quality of life.

Prevalence rates appear similar across countries and ethnic groups, suggesting endometriosis is a truly global health challenge [2]. Despite this, the resources allocated to research, education, and clinical care vary dramatically depending on where a person lives.

Healthcare Disparities Around the World

The management and treatment of endometriosis vary significantly across regions. These disparities are shaped by economics, infrastructure, medical training, cultural norms, and health policy.

High-Income Countries

In wealthier nations, patients generally have better access to specialized care, though significant gaps remain. Advantages often include:

• Greater availability of laparoscopic excision surgery
• More specialized endometriosis treatment centers
• Higher awareness and training among healthcare providers
• More robust research funding and clinical trial infrastructure
• Better access to multidisciplinary pain management

Even in these settings, diagnostic delays are common, and many patients still struggle to find surgeons skilled in excision techniques. The ESHRE guideline provides a widely referenced framework for diagnosis and treatment in well-resourced settings [3].

Low and Middle-Income Countries

In many low- and middle-income countries, people with endometriosis face compounded challenges. Barriers to timely and effective care include:

• Limited access to specialized surgical care and excision specialists
• Fewer diagnostic imaging and laboratory resources
• Lower awareness of endometriosis among healthcare providers
• Minimal public and private research funding
• Cultural stigma and barriers to discussing menstrual health
• High out-of-pocket costs and limited insurance coverage

These disparities contribute to even longer diagnostic delays and greater disease burden in underserved regions [4].

Global Challenges in Endometriosis Care

1. Diagnostic Delays

The worldwide challenge of delayed diagnosis stems from multiple factors. On average, it takes 7 to 10 years from the onset of symptoms to receive a diagnosis, and this delay is often longer in settings with fewer resources or greater stigma [2] [4].

2. Treatment Access

Significant disparities exist in access to quality treatment. Excision surgery, considered the gold standard for many forms of endometriosis, requires specialized training that is not available everywhere. Other access issues include:

• Limited availability of skilled excision surgeons, especially in rural or underserved areas
• High cost of surgical treatment and long waiting lists in public health systems
• Varying insurance coverage and reimbursement for specialist care
• Limited access to hormone treatments, pelvic floor therapy, and pain management in some regions [4]

3. Educational Gaps

Educational challenges persist globally. Insufficient medical training about endometriosis leads to underdiagnosis and mismanagement, while limited public health education leaves patients unaware that their symptoms may be treatable. Cultural taboos surrounding menstruation and pelvic pain further silence those suffering, and language barriers can limit access to reliable information [2] [5].

Global Initiatives and Progress

Research Collaboration

International research efforts are advancing our understanding of endometriosis. Key initiatives include:

• The World Endometriosis Research Foundation (WERF): Supporting global, multi-center studies to identify risk factors, biomarkers, and treatment outcomes.
• Global studies on environmental factors: Investigating how exposures such as endocrine-disrupting chemicals may influence endometriosis risk.
• Genetic research across populations: Genome-wide association studies are helping identify shared genetic risk factors and disease mechanisms.
• Biomarker studies: Researchers are working toward non-invasive diagnostic tools, including blood, urine, and imaging markers [2] [5].

Healthcare Policy Changes

Several countries and organizations are implementing positive changes:

The Role of Global Health Engagement

Current Initiatives

Patient advocacy and global health engagement are driving visibility and change. Current efforts include:

• EndoMarch World Awareness Campaign: A global movement raising awareness through events, education, and advocacy.
• Global research consortiums: Collaborative networks working to standardize data collection and share findings across borders.
• International physician training programs: Initiatives to increase the number of surgeons skilled in endometriosis excision, particularly in underserved regions.
• Patient advocacy networks: Grassroots and international organizations providing support, education, and a unified voice for people with endometriosis [2].

Future Priorities

To make meaningful progress, the global community must prioritize:

• Establishing universal care standards adapted to local contexts
• Improving access to surgical expertise through training and telemedicine
• Developing affordable, accessible treatment options
• Creating multilingual, culturally appropriate educational resources
• Building global support networks that connect patients, advocates, and clinicians [2] [5]

Call to Action

Global Health Engagement Month provides an opportunity to highlight the worldwide impact of endometriosis and the urgent need for coordinated international action. By addressing healthcare disparities, improving education, and supporting research initiatives, we can work toward better outcomes for endometriosis patients everywhere.

The path forward requires collaboration across borders, cultures, and healthcare systems. Only through unified global effort can we hope to reduce diagnostic delays, improve treatment access, and ultimately enhance the quality of life for millions affected by endometriosis worldwide.

Need Support?

Navigating endometriosis care can feel overwhelming, especially when facing barriers to diagnosis or treatment. You are not alone. Our Mentorship program connects you with experienced patient advocates who can help you prepare questions, understand your options, and find knowledgeable care.

Schedule a Mentorship Session Today

Remember: Peer support and mentorship are not medical advice, diagnosis, or treatment. Always consult qualified healthcare providers for personalized medical guidance.

Sources

1. World Health Organization. (2023). "Endometriosis Fact Sheet." https://www.who.int/news-room/fact-sheets/detail/endometriosis
2. Zondervan, K. T., Becker, C. M., & Missmer, S. A. (2018). "Endometriosis." Nature Reviews Disease Primers, 4, 9. https://pubmed.ncbi.nlm.nih.gov/28617154/
3. ESHRE Guideline Group. (2022). "ESHRE guideline: endometriosis." Human Reproduction Open, 2022(2), hoac009. https://pubmed.ncbi.nlm.nih.gov/35688837/
4. As-Sanie, S., Black, R., Giudice, L. C., et al. (2019). "Assessing Research Gaps and Unmet Needs in Endometriosis." American Journal of Obstetrics and Gynecology, 221(2), 86-94. https://pubmed.ncbi.nlm.nih.gov/30879668/
5. Rogers, P. A., D'Hooghe, T. M., Fazleabas, A., et al. (2017). "Priorities for endometriosis research: recommendations from an international consensus workshop." Reproductive Sciences, 24(3), 335-349. https://pubmed.ncbi.nlm.nih.gov/28158953/
6. Simoens, S., Dunselman, G., Dirksen, C., et al. (2012). "The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres." Human Reproduction, 27(5), 1292-1299. https://pubmed.ncbi.nlm.nih.gov/22419705/
7. Johnson, N. P., Hummelshoj, L., Adamson, G. D., et al. (2017). "World Endometriosis Society consensus on the classification of endometriosis." Human Reproduction, 32(8), 1552-1563. https://pubmed.ncbi.nlm.nih.gov/28617154/
8. Agarwal, S. K., Chapron, C., Giudice, L. C., et al. (2019). "Clinical diagnosis of endometriosis: a call to action." American Journal of Obstetrics and Gynecology, 220(4), 354.e1-354.e12. https://pubmed.ncbi.nlm.nih.gov/30529016/
9. World Endometriosis Research Foundation. (2021). "Global Study of Women's Health." https://worldendometriosis.org/
10. GBD 2019 Diseases and Injuries Collaborators. (2020). "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019." The Lancet, 396(10258), 1204-1222. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext
11. Department of Health, Australian Government. (2018). "National Action Plan for Endometriosis." https://www.health.gov.au/resources/publications/national-action-plan-for-endometriosis
12. World Endometriosis Society. (2022). "Global Consortium of Investigators in Endometriosis." https://worldendometriosis.org/
13. Adamson, G. D., Kennedy, S. H., & Hummelshoj, L. (2010). "Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation." Journal of Endometriosis, 2(3), 131-134. https://pubmed.ncbi.nlm.nih.gov/21113292/
14. Nnoaham, K. E., Hummelshoj, L., Webster, P., et al. (2011). "Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries." Fertility and Sterility, 96(2), 366-373. https://pubmed.ncbi.nlm.nih.gov/21621771/

Note: Please consult with healthcare professionals for personalized medical advice. This article is for informational purposes only.